10th April 2012

Thermo Fisher Scientific Celebrates 50 years in drug discovery and development

MediWales member Thermo Fisher Scientific, celebrates 50 years of its Maybrdige line of chemistrty products 

Thermo Fisher Scientific announced on the April 5th the 50th anniversary of its Maybridge chemistry products – an evolving line of bioactive molecules to accelerate drug discovery and development. The Maybridge business became part of Thermo Fisher in 2002.

The Maybridge line is a comprehensive range of innovative and diverse drug-like molecules and compound libraries for traditional drug-discovery screening, as well as fragment-based programs. These products are used by researchers worldwide to accelerate the identification and development of lead compounds for potential new drug therapies.

The Maybridge line now encompasses more than 56,000 pre-plated drug-like screening compounds. These compounds comprise screening collections such as the renowned HitFinder™ and Ro3 Diversity Fragment libraries and an expanding range of highly reactive heterocyclic building blocks.

“We are very proud that after 50 years Maybridge products continue to enable discovery,” said Simon Pearce, product manager for Maybridge and Acros Organics products at Thermo Fisher. “We continue to evolve to better serve our customers and have just completed our move from Tintagel, England to the Thermo Fisher site in Loughborough, where we will further strengthen our core offerings and improve our service to our customers worldwide. Our new location will allow us to leverage the dedicated technical, supply-chain and operational teams that support other world-class Thermo Fisher Scientific chemical product lines.”

For more information, please visit www.maybridge.com.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Their mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, they have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries.

The Thermo Fisher Scientific site in Wales (formally Sterilin Ltd) is based in Newport. Sterilin was acquired by Thermo Fisher Scientific in May 2011. www.thermofisher.com